Stay updated with breaking news from Mablink Adcs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners
Investegate announcements from Mablink Bioscience, Mablink Bioscience announces a 31 million Series A
The financing will enable the company to advance its lead candidate to the clinic and to build a pipeline of next-generation antibody-drug conjugates (ADCs)Its proprietary ADC technology opens the door